Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".
Patricia McGettiganCarla Alonso OlmoKelly PlueschkeMireia CastillonDaniel ZondagPriya BahriXavier KurzPeter G M MolPublished in: Drug safety (2020)
Keyphrases